First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study - D'Angelo, Sandra P.; Lebbe, Celeste; Mortier, Laurent; Brohl, Andrew S.; Fazio, Nicola; Grob, Jean-Jacques; Prinzi, Natalie; Hanna, Glenn J.; Hassel, Jessica C.; Kiecker, Felix; Georges, Sara; Ellers-Lenz, Barbara; et al. (Journal for ImmunoTherapy of Cancer, 2021)
Gesehen am 24.01.2022